1.
Davidoff AJ, Smith SW, Baer MR, Ke X, Bierenbaum JM, Hendrick F, McNally DL, Gore SD. Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes. Haematologica 2011; 97(1):128-132; https://doi.org/10.3324/haematol.2011.049130.